Ardent Health Partners, LLC (ARDT) 当前追踪市盈率 (P/E) 为 9.6, 前瞻市盈率为 8.3. 追踪盈利收益率为 10.39%, 前瞻盈利收益率 12.09%. PEG 0.44 (Peter Lynch 低估标准 ≤1.0). 格雷厄姆数为 $16.12.
本页证实的标准:
SharesGrow 综合评分： 74/100 其中 5/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2015 | -48.8 | 0.00 | 0.00 | 1.12 | 24.67% |
| 2016 | 155.0 | -1.19 | 8.49 | 1.08 | - |
| 2017 | -63.5 | 0.18 | 5.99 | 0.75 | - |
| 2018 | -15.8 | -0.05 | 6.83 | 0.54 | - |
| 2021 | 14.9 | 0.00 | 0.00 | 0.47 | 2.70% |
| 2022 | 12.2 | 0.55 | 3.60 | 0.45 | 7.60% |
| 2023 | 45.7 | -0.62 | 3.43 | 0.43 | - |
| 2024 | 10.8 | 0.03 | 2.00 | 0.38 | - |
| 2025 | 9.2 | -0.23 | 0.74 | 0.20 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2015 | $-0.33 | $2.03B | $-46.36M | -2.3% |
| 2016 | $0.10 | $2.11B | $14.6M | 0.7% |
| 2017 | $-0.25 | $3B | $-35.65M | -1.2% |
| 2018 | $-1.01 | $4.16B | $-143.02M | -3.4% |
| 2021 | $1.09 | $4.87B | $154.26M | 3.2% |
| 2022 | $1.32 | $5.13B | $188.91M | 3.7% |
| 2023 | $0.35 | $5.41B | $50.29M | 0.9% |
| 2024 | $1.58 | $5.97B | $210.34M | 3.5% |
| 2025 | $0.96 | $6.32B | $135.81M | 2.1% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $1.14 | $1.03 – $1.37 | $6.57B | $6.55B – $6.61B | 7 |
| 2027 | $1.26 | $1.02 – $1.48 | $6.85B | $6.79B – $6.9B | 6 |
| 2028 | $1.34 | $1.07 – $1.57 | $7.2B | $7.2B – $7.2B | 6 |
